Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000601788 | SCV000725148 | likely benign | not specified | 2017-11-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Blueprint Genetics | RCV000788533 | SCV000927682 | uncertain significance | not provided | 2018-05-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003302948 | SCV003996339 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-04-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003594003 | SCV004290854 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-12-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003962792 | SCV004781759 | likely benign | COL5A1-related disorder | 2020-02-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |